Avience Biomedicals IPO Timeline
The Avience Biomedicals IPO is a book build issue with a total issue size of ₹30 cr, comprising of fresh issue of 1371600 equity shares.
Avience Biomedicals IPO opened for subscription on Jun 18, 2026 and closed on Jun 22, 2026. The basis of allotment got finalized on Jun 23, 2026, and listed on the NSE on Jun 25, 2026.
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Avience Biomedicals IPO Timeline (Tentative)
- IPO Open Date
- Thursday, 18 June 2026
- IPO Close Date
- Monday, 22 June 2026
- Basis of Allotment
- Tuesday, 23 June 2026
- Initiation of Refunds
- Wednesday, 24 June 2026
- Credit of Shares to Demat
- Wednesday, 24 June 2026
- Listing Date
- Thursday, 25 June 2026 — NSE & BSE
Important Dates
Open Date
18 June 2026
Close Date
22 June 2026
Basis Of Allotment
23 June 2026
Listing Date
25 June 2026
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Avience Biomedicals IPO is a Book-building IPO with a total issue size of ₹30 crore. The Avience Biomedicals IPO price band is ₹196 to 208 per share. The Avience Biomedicals IPO subscription opens on Thu, Jun 18, 2026, and closes on Mon, Jun 22, 2026. The Avience Biomedicals IPO will be listed on the NSE. Skyline Financial Services Private Ltd is the registrar for the Avience Biomedicals IPO.
The Avience Biomedicals IPO opens on Thu, Jun 18, 2026 and closes on Mon, Jun 22, 2026
Avience Biomedicals IPO Price Band is ₹196 to 208 per share.
Avience Biomedicals IPO lot size is 600 shares, Retail investors need a minimum investment of ₹249600 based on the upper price band
The minimum investment for Avience Biomedicals IPO is ₹249600, based on one lot of 600 shares at the upper price band of ₹208 per share.
Investors can apply for the Avience Biomedicals IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Mon, Jun 22, 2026. The application amount remains blocked until the Avience Biomedicals IPO allotment is finalized.
Avience Biomedicals IPO issue size is ₹30 crores.
Avience Biomedicals IPO allotment date is Wed, Jul 1, 2026.
The registrar for Avience Biomedicals IPO is Skyline Financial Services Private Ltd. Investors can go to Skyline Financial Services Private Ltd website to check Avience Biomedicals IPO allotment status, refund processing, and other IPO-related information.
The Avience Biomedicals IPO GMP (Grey Market Premium) is ₹145 as of Thu, Jun 25, 2026. Based on the upper price band of ₹208 per share, the estimated Avience Biomedicals IPO listing price is ₹353, indicating a potential listing gain of approximately 0% over the issue price.